Boryung
003850
Company Profile
Business description
Boryung is part of the healthcare sector. The company's business involves the manufacture and marketing of pharmaceutical products. It manufactures a suite of drugs to address various areas such as blood circulation, gastrointestinal, and hypertension. Boryung markets its products globally through over 100 partners.
Contact
136, Changgyeonggung-ro
Boryeong Building
Jongno-gu
Seoul110-750
KORT: +82 807088088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,651
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.80 | 7.50 | -0.08% |
| CAC 40 | 8,152.12 | 83.50 | 1.03% |
| DAX 40 | 24,281.60 | 95.11 | 0.39% |
| Dow JONES (US) | 48,458.05 | 245.96 | -0.51% |
| FTSE 100 | 9,740.77 | 91.74 | 0.95% |
| HKSE | 25,628.88 | 347.91 | -1.34% |
| NASDAQ | 23,195.17 | 398.69 | -1.69% |
| Nikkei 225 | 50,168.11 | 668.44 | -1.31% |
| NZX 50 Index | 13,408.14 | 1.23 | 0.01% |
| S&P 500 | 6,827.41 | 73.59 | -1.07% |
| S&P/ASX 200 | 8,635.00 | 8.90 | -0.10% |
| SSE Composite Index | 3,867.92 | 21.42 | -0.55% |